Abingdon Health Plc (AIM:ABDX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 9.00
0.00 (0.00%)
Oct 23, 2026, 9:52 AM BST
Abingdon Health Income Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 10.99 | 8.43 | 6.14 | 4.05 | 2.84 | |
Revenue Growth | 30.42% | 37.39% | 51.67% | 42.68% | -75.60% |
Cost of Revenue | 5.82 | 4.69 | 2.46 | 1.97 | 6.43 |
Gross Profit | 5.18 | 3.74 | 3.68 | 2.08 | -3.59 |
Selling, General & Admin | 7.9 | 7.71 | 5.31 | 5.22 | 6.65 |
Amortization of Goodwill & Intangibles | 0.12 | 0.11 | 0.03 | 0.03 | 0.12 |
Other Operating Expenses | -0.7 | -0.47 | -0.26 | -0.25 | -0.24 |
Operating Expenses | 8.01 | 8.07 | 5.53 | 5.69 | 8.27 |
Operating Income | -2.83 | -4.33 | -1.85 | -3.61 | -11.87 |
Interest Expense | -0.04 | -0.07 | -0.05 | -0.07 | -0.07 |
Interest & Investment Income | 0.04 | 0.1 | 0.03 | 0.09 | 0 |
Other Non Operating Income (Expenses) | 0.78 | 0.44 | 0.24 | 0.39 | - |
EBT Excluding Unusual Items | -2.06 | -3.86 | -1.63 | -3.21 | -11.93 |
Merger & Restructuring Charges | - | - | -0.11 | -0.16 | -0.2 |
Impairment of Goodwill | - | - | - | - | -0.76 |
Gain (Loss) on Sale of Investments | - | 0.01 | - | - | - |
Asset Writedown | - | 0.14 | - | -0.09 | -6.43 |
Legal Settlements | - | - | - | - | -1.59 |
Other Unusual Items | 0.04 | 0.21 | 0.34 | -0.12 | -0.69 |
Pretax Income | -2.02 | -3.5 | -1.4 | -3.57 | -21.59 |
Income Tax Expense | 0.11 | -0.08 | -0.13 | -0.11 | -0.33 |
Net Income | -2.13 | -3.42 | -1.27 | -3.47 | -21.26 |
Net Income to Common | -2.13 | -3.42 | -1.27 | -3.47 | -21.26 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 414 | 367 | 305 | 304 | 292 |
Shares Outstanding (Diluted) | 414 | 367 | 305 | 304 | 292 |
Shares Change | 12.96% | 20.32% | 0.23% | 4.26% | 4.89% |
EPS (Basic) | -0.01 | -0.01 | -0.00 | -0.01 | -0.07 |
EPS (Diluted) | -0.01 | -0.01 | -0.00 | -0.01 | -0.07 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -1.8 | -3.51 | -1.69 | 0.84 | -8.42 |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | 0.00 | -0.03 |
Gross Margin | 47.10% | 44.32% | 59.97% | 51.30% | -126.70% |
Operating Margin | -25.77% | -51.38% | -30.11% | -89.27% | -418.52% |
Profit Margin | -19.36% | -40.52% | -20.72% | -85.76% | -749.98% |
Free Cash Flow Margin | -16.38% | -41.63% | -27.61% | 20.72% | -297.04% |
EBITDA | -2.32 | -3.87 | -1.49 | -2.98 | -10.59 |
EBITDA Margin | -21.12% | -45.87% | -24.29% | -73.75% | - |
D&A For EBITDA | 0.51 | 0.47 | 0.36 | 0.63 | 1.28 |
EBIT | -2.83 | -4.33 | -1.85 | -3.61 | -11.87 |
EBIT Margin | -25.77% | -51.38% | -30.11% | -89.27% | - |